Clinical Trials · NCT01076842
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 75
- Start date
- Apr 2008
- Locations
- 2 sites, United States
- Primary endpoint
- The primary endpoint is the improvement in A1C goal measured in mean reduction in A1c levels over 24 weeks.